Drug Delivery Insights
Key reasons behind surge in semaglutide usage
Semaglutide usage has surged in recent years due to FDA approval for its wider usage in weight loss management, providing a legal and regulated avenue for the drug to be prescribed. Read more
30 Sep 2024
Pharmaceutical Drugs Innovations: Revolutionising Biological Drug Delivery
Professor Afzal R Mohammed, Professor of Pharmaceutics at Aston University and advisor to Max Bio+, explores two promising advancements being explored that could revolutionise biological drug delivery: liquid-based delivery and inhalation. Read more
13 Dec 2023
Innovation in Inhalation: The Future of Drug Delivery
Broughton's new inhalation testing service propels inhaled drug delivery into an innovative future. Read more
19 Jun 2023
Broughton speaks to EPM on the latest in inhaled medicines testing
EPM speaks to Chris Allen, CEO of scientific consultancy and Contract Research Organisation (CRO) Broughton, which has just launched a new inhalation testing service. Read more
8 Jun 2023
Answering pharma’s call for smarter solutions with Ready-To-Use vials
Fabio Bertacchini, Senior Director of Product, Proposal and Technical Account Management at Stevanato Group shares how Ready-To-Use vials are answering pharma's call for solutions to aseptic manufacturing challenges. Read more
3 Apr 2023
The future of patient experience: how connected drug delivery will promote inclusivity and adherence
Michael Earl, director, pharmaceutical services at Owen Mumford, examines the benefits that patients are set to receive as the connected drug delivery devices market grows. Read more
6 Feb 2023
Stevanato introduces on-body delivery system at CPHI Milan
Stevanato Group announced the expansion of its Vertiva platform, which will include a 10mL option to be presented at CPHI Milan in October. Read more
4 Oct 2024
SHL Medical's Elexy advances drug-device development
SHL Medical has adopted a new reusable electromechanical autoinjector Elexy which changes how new drugs are trialled and commercialised, shortening these processes. Read more
2 Oct 2024
Renaissance supports nasal spray launch for life-threatening allergies
Renaissance Lakewood is manufacturing FDA-approved neffy, from ARS Pharmaceutical, which is now commercially available in the US. Read more
1 Oct 2024
A new era of biopharmaceutical packaging solutions
James Bury, director technology at Tjoapack, examines the increasing need for innovative solutions in pharmaceutical packaging, emphasising novel approaches and emerging technologies that address changing packaging requirements. Read more
9 Oct 2024
Mapping the counterfeit and diversion epidemic in the pharma industry
Stephan Von Schilcher, global strategic account manager at Systech, discusses the repercussions of counterfeit drug epidemic on patients and what pharma companies must to combat the problem. Read more
9 Oct 2024
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
What Solutum's collab with pester pac means for pharma packaging
In an interview following FACHPACK, editor Rebekah Jordan caught up with Sharon Barak, president and co-founder of Solutum, on the reasons behind their partnership with pester pac and the wider pharma packaging challenges it addresses. Read more
4 Oct 2024
Behind the scenes: 35 years of CPHI
EPM got a sneak preview of what to expect at CPHI's 35th anniversary next week from Tara Dougal, brand and content director at CPHI Milan. Read more
3 Oct 2024
BLA and Tides to surpass small molecules, CPHI Milan report predicts
The CPHI Annual Industry Survey reveals that the pharma sector is on the cusp of a major shift, with approvals for complex molecules expected to outpace those for small molecules for the first time. Read more
3 Oct 2024
Enhancing pharma innovation with biofermentation and synthesis
David Blanco, Industrial BD & CDMO director, Suanfarma, shares how the pharma industry can enhance innovation by combining biofermentation and chemical synthesis, while highlighting the importance of technology transfer for implementation of both. Read more
3 Oct 2024